AxoGen, Inc. LT3.F Stock
AxoGen, Inc. Price Chart
AxoGen, Inc. LT3.F Financial and Trading Overview
AxoGen, Inc. stock price | 6.75 EUR |
Previous Close | 8.7 EUR |
Open | 8.6 EUR |
Bid | 8.6 EUR x 0 |
Ask | 8.9 EUR x 0 |
Day's Range | 8.6 - 8.6 EUR |
52 Week Range | 6.85 - 12.8 EUR |
Volume | 400 EUR |
Avg. Volume | 0 EUR |
Market Cap | 376.26M EUR |
Beta (5Y Monthly) | 0.605985 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.48 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 27 EUR |
LT3.F Valuation Measures
Enterprise Value | 406.54M EUR |
Trailing P/E | N/A |
Forward P/E | -33.076927 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.6085832 |
Price/Book (mrq) | 3.7752414 |
Enterprise Value/Revenue | 2.819 |
Enterprise Value/EBITDA | -17.966 |
Trading Information
AxoGen, Inc. Stock Price History
Beta (5Y Monthly) | 0.605985 |
52-Week Change | 18.49% |
S&P500 52-Week Change | 20.43% |
52 Week High | 12.8 EUR |
52 Week Low | 6.85 EUR |
50-Day Moving Average | 8.48 EUR |
200-Day Moving Average | 9.47 EUR |
LT3.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 42.83M |
Float | 36.88M |
Short Ratio | N/A |
% Held by Insiders | 4.94% |
% Held by Institutions | 77.58% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -17.018% |
Operating Margin (ttm) | -17.83% |
Gross Margin | 82.45% |
EBITDA Margin | -15.68% |
Management Effectiveness
Return on Assets (ttm) | -8.29% |
Return on Equity (ttm) | -24.38% |
Income Statement
Revenue (ttm) | 144.24M EUR |
Revenue Per Share (ttm) | 3.41 EUR |
Quarterly Revenue Growth (yoy) | 18.19% |
Gross Profit (ttm) | 114.44M EUR |
EBITDA | -22629000 EUR |
Net Income Avi to Common (ttm) | -24547000 EUR |
Diluted EPS (ttm) | -0.57 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 37.87M EUR |
Total Cash Per Share (mrq) | 0.88 EUR |
Total Debt (mrq) | 71.77M EUR |
Total Debt/Equity (mrq) | 73.6 EUR |
Current Ratio (mrq) | 4.176 |
Book Value Per Share (mrq) | 2.278 |
Cash Flow Statement
Operating Cash Flow (ttm) | -12438000 EUR |
Levered Free Cash Flow (ttm) | -21256750 EUR |
Profile of AxoGen, Inc.
Country | Germany |
State | FL |
City | Alachua |
Address | 13631 Progress Blvd. |
ZIP | 32615 |
Phone | 386 462 6800 |
Website | https://www.axogeninc.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 394 |
AxoGen, Inc., together with its subsidiaries, develops and markets technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.
Q&A For AxoGen, Inc. Stock
What is a current LT3.F stock price?
AxoGen, Inc. LT3.F stock price today per share is 6.75 EUR.
How to purchase AxoGen, Inc. stock?
You can buy LT3.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AxoGen, Inc.?
The stock symbol or ticker of AxoGen, Inc. is LT3.F.
Which industry does the AxoGen, Inc. company belong to?
The AxoGen, Inc. industry is Medical Devices.
How many shares does AxoGen, Inc. have in circulation?
The max supply of AxoGen, Inc. shares is 43.69M.
What is AxoGen, Inc. Price to Earnings Ratio (PE Ratio)?
AxoGen, Inc. PE Ratio is now.
What was AxoGen, Inc. earnings per share over the trailing 12 months (TTM)?
AxoGen, Inc. EPS is -0.48 EUR over the trailing 12 months.
Which sector does the AxoGen, Inc. company belong to?
The AxoGen, Inc. sector is Healthcare.